Apparent Mineralocorticoid Excess: A Patient Guide
At a Glance
Apparent mineralocorticoid excess is a rare condition in which cortisol falsely activates the kidneys’ salt-retaining signals, causing high blood pressure, salt and water retention, and low potassium. Treatment combines receptor-blocking medicines, potassium, a low-sodium diet, and monitoring.
Apparent Mineralocorticoid Excess (AME) is a rare condition that fundamentally changes how the kidneys manage the delicate balance of salt and potassium. In a typical body, an enzyme called 11β-HSD2 acts as a protective filter in the kidneys, preventing the stress hormone cortisol from activating the body’s “salt-saving” receptors. In people with AME, this enzyme is either deficient or temporarily inhibited, allowing cortisol to reach those receptors and trick the body into behaving as though it has an excess of the salt-retaining hormone aldosterone [1][2].
The result of this biological “case of mistaken identity” is that the kidneys aggressively hold onto sodium and water while simultaneously losing too much potassium. This imbalance leads to the hallmark features of the condition: severe high blood pressure and low potassium levels that often appear early in childhood, though milder forms can present later. Because the body is under constant pressure from these signals, patients may experience challenges with growth and energy levels, though these often improve significantly once the right management plan is in place [3][4].
Living with AME requires a focused, lifelong approach to care that centers on three main pillars: medication, diet, and consistent monitoring. Specialists use medications called mineralocorticoid receptor antagonists to block the kidney’s receptors from the false signals from cortisol. This is paired with potassium supplements to replace what the kidneys lose and a low-sodium diet to reduce the workload on the heart and kidneys. While the condition is complex, these treatments are effective at controlling blood pressure and protecting long-term organ health [5][6].
While the journey of managing a rare diagnosis can feel overwhelming, it is important to remember that AME is a manageable condition. With a dedicated care team and modern treatment strategies, patients with AME can thrive, meet their developmental milestones, and lead full, active lives. Your role is to be the steady anchor in this process, ensuring that the daily balance of salt and hormones is maintained so you or your child can focus on living well [7][8].
In this guide
6 chapters
Understanding Apparent Mineralocorticoid Excess
Learn what apparent mineralocorticoid excess (AME) is, why it causes high blood pressure and low potassium, and how genetic and acquired forms are diagnosed.
The Biology and Diagnosis of AME
Learn how apparent mineralocorticoid excess (AME) is diagnosed through renin, aldosterone, potassium, cortisol-to-cortisone ratios, and HSD11B2 genetic testing.
Symptoms, Warning Signs & Emergencies
Learn the symptoms of apparent mineralocorticoid excess, including high blood pressure and low-potassium warning signs, and when to seek emergency care.
Treatment and Day-to-Day Management
Learn how apparent mineralocorticoid excess is treated with receptor blockers, potassium monitoring, low-sodium eating, dexamethasone, and kidney-protective care
Monitoring and Long-Term Outlook
Learn how AME monitoring protects kidney, heart, and eye health, including blood pressure, potassium, growth, kidney scans, and long-term complications.
Building Your Care Team and First Visit Prep
Learn how to build an apparent mineralocorticoid excess care team, prepare genetic and urinary steroid reports, track blood pressure, and plan visits.
Common questions in this guide
What causes apparent mineralocorticoid excess?
What symptoms does AME cause?
How is apparent mineralocorticoid excess treated?
Will AME require lifelong care?
Can a child with AME grow and live an active life?
How can families stay organized while managing AME?
Get notified when new evidence is published on Apparent mineralocorticoid excess.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
The Dehydrogenase Hypothesis.
Woods C, Tomlinson JW
Advances in experimental medicine and biology 2015; (872()):353-80 doi:10.1007/978-1-4939-2895-8_16.
PMID: 26216003 - 2
Alterations of Cortisol Metabolism in Human Disorders.
White PC
Hormone research in paediatrics 2018; (89(5)):320-330 doi:10.1159/000485508.
PMID: 29843121 - 3
Apparent mineralocorticoid excess mimicking Bartter syndrome in infancy.
Hatipoğlu S, Yıldırım E, Şalbaş ÖY, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0333.
PMID: 42912472 - 4
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics.
Lu YT, Zhang D, Zhang QY, et al.
Journal of translational medicine 2022; (20(1)):500 doi:10.1186/s12967-022-03698-9.
PMID: 36329487 - 5
Case report: Clinical characteristics and Genetical analysis of HSD11B2 in three Chinese children with apparent mineralocorticoid excess: a case series.
Ding Y, Cheng M, Cao B, et al.
Frontiers in endocrinology 2024; (15()):1491825 doi:10.3389/fendo.2024.1491825.
PMID: 39931437 - 6
Apparent mineralocorticoid excess and the long term treatment of genetic hypertension.
Razzaghy-Azar M, Yau M, Khattab A, New MI
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):145-150 doi:10.1016/j.jsbmb.2016.02.014.
PMID: 26892095 - 7
Apparent mineralocorticoid excess in Israel: a case series and literature review.
Lebel A, Ben Shalom E, Mokatern R, et al.
European journal of endocrinology 2024; (190(5)):347-353 doi:10.1093/ejendo/lvae049.
PMID: 38652803 - 8
Apparent mineralocorticoid excess with a novel HSD11B2 variant: longitudinal clinical and biochemical follow-Up.
Nalluri BT, Kudugunti N, Sahay RK
JCEM case reports 2026; (4(6)):luag083 doi:10.1210/jcemcr/luag083.
PMID: 42064719
This page explains apparent mineralocorticoid excess for informational purposes only and does not constitute medical advice. Work with your healthcare team to individualize medicines, potassium, diet, and monitoring for you or your child.